-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Maintains Market Perform on Amgen, Raises Price Target to $464

Benzinga·11/05/2026 22:11:28
Leerink Partners analyst David Risinger maintains Amgen (NASDAQ:AMGN) with a Market Perform and raises the price target from $395 to $464.